Yahoo Web Search

Search results

  1. Oct 24, 2013 · The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in...

    • F Ann Ran, Patrick D Hsu, Jason Wright, Vineeta Agarwala, Vineeta Agarwala, David A Scott, Feng Zhan...
    • 2013
  2. Zhang pioneered the development of CRISPR-Cas9 as a genome editing tool and its use in eukaryotic cells –including human cells – from a natural adaptive immune system found in bacteria. He has substantially expanded this toolbox through discovery and harnessing of new CRISPR and CRISPR-associated systems.

  3. en.wikipedia.org › wiki › Feng_ZhangFeng Zhang - Wikipedia

    Zhang, Doudna, and other colleagues from Harvard founded Editas Medicine in September 2013 to develop and commercialize CRISPR-based therapies. Zhang discovered Cas13 with Harvard colleague Eugene Koonin using computational biology methods. In 2016, Zhang cofounded Arbor Biotechnologies to develop Cas13 for therapeutic use.

  4. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity FA Ran, PD Hsu, CY Lin, JS Gootenberg, S Konermann, AE Trevino, ... Cell 154 (6), 1380-1389 , 2013

  5. Zhang is a molecular biologist developing and applying novel molecular technologies for studying the brain. Zhang pioneered the development of genome editing tools for use in eukaryotic cells – including human cells – from natural microbial CRISPR-Cas9 systems.

  6. Jun 28, 2023 · A team of researchers led by Feng Zhang at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard has uncovered the first programmable RNA-guided system in eukaryotes — organisms that include fungi, plants, and animals.

  7. People also ask

  8. Dr. Zhang is a molecular biologist focused on improving human health. He played an integral role in the development of two revolutionary technologies, optogenetics and CRISPR-Cas systems, including pioneering the use of Cas9 for genome editing and discovering CRISPR-Cas12 and Cas13 systems and developing them for therapeutic and diagnostic ...

  1. People also search for